HONOLULU (Island News) — Hawaii consumers who purchased generic drugs between May 1, 2009 and Dec. 31, 2019 may be eligible for potential compensation.

The announcement from Attorney General Anne Lopez follows a court-approved settlement with Apotex Corp., a generic drug manufacturer. This settlement addresses certain claims in antitrust and consumer protection lawsuits in the U.S. District Courts for the District of Connecticut and the Eastern District of Pennsylvania.

The lawsuits allege that some generic drug manufacturers conspired to artificially inflate and manipulate drug prices, reduce competition and unreasonably restrain trade regarding numerous generic prescription drugs.

A final list of generic drugs involved and a distribution plan have yet to be approved by the court. Registration ensures that Hawaii consumers will be notified of future settlements and the claims filing process.

A partial list of drugs involved in the settlement can be found by visiting aggenericdrugs.com/English/Drug-List. They can register their contact information at www.AGGenericDrugs.com or by calling 1-866-290-0182.


Queen’s North Hawaii Hospital nurses ratify new contract